KR900701299A - Cpf 펩티드 조성물 및 이를 사용하는 방법 - Google Patents

Cpf 펩티드 조성물 및 이를 사용하는 방법

Info

Publication number
KR900701299A
KR900701299A KR1019900701329A KR900701329A KR900701299A KR 900701299 A KR900701299 A KR 900701299A KR 1019900701329 A KR1019900701329 A KR 1019900701329A KR 900701329 A KR900701329 A KR 900701329A KR 900701299 A KR900701299 A KR 900701299A
Authority
KR
South Korea
Prior art keywords
same
peptide composition
cpf peptide
cpf
peptides
Prior art date
Application number
KR1019900701329A
Other languages
English (en)
Inventor
미카엘 자스로프
Original Assignee
마게이닌 사이언시스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마게이닌 사이언시스 인코포레이티드 filed Critical 마게이닌 사이언시스 인코포레이티드
Publication of KR900701299A publication Critical patent/KR900701299A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
KR1019900701329A 1988-10-21 1990-06-21 Cpf 펩티드 조성물 및 이를 사용하는 방법 KR900701299A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26086188A 1988-10-21 1988-10-21
US36268989A 1989-06-07 1989-06-07
PCT/US1989/004625 WO1990004407A1 (en) 1988-10-21 1989-10-16 Cpf peptide compositions and uses

Publications (1)

Publication Number Publication Date
KR900701299A true KR900701299A (ko) 1990-12-01

Family

ID=26948228

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701329A KR900701299A (ko) 1988-10-21 1990-06-21 Cpf 펩티드 조성물 및 이를 사용하는 방법

Country Status (10)

Country Link
EP (1) EP0440688B1 (ko)
JP (1) JPH04502901A (ko)
KR (1) KR900701299A (ko)
CN (1) CN1043874A (ko)
AT (1) ATE111742T1 (ko)
AU (1) AU4410989A (ko)
CA (1) CA2001008A1 (ko)
DE (1) DE68918453T2 (ko)
IL (1) IL92030A (ko)
WO (1) WO1990004407A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
AU654714B2 (en) * 1991-04-08 1994-11-17 Magainin Pharmaceuticals, Inc. Novel peptide compositions and uses therefor
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
GB9501300D0 (en) * 1995-01-24 1995-03-15 Boughton Brian J Peptides which inhibit viruses
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
JP3860838B2 (ja) 1995-08-23 2006-12-20 ユニバーシティー オブ ブリティッシュ コロンビア 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use

Also Published As

Publication number Publication date
JPH04502901A (ja) 1992-05-28
WO1990004407A1 (en) 1990-05-03
EP0440688A1 (en) 1991-08-14
DE68918453D1 (de) 1994-10-27
EP0440688B1 (en) 1994-09-21
ATE111742T1 (de) 1994-10-15
CN1043874A (zh) 1990-07-18
CA2001008A1 (en) 1990-04-21
DE68918453T2 (de) 1995-02-23
EP0440688A4 (en) 1992-07-08
IL92030A (en) 1994-05-30
AU4410989A (en) 1990-05-14

Similar Documents

Publication Publication Date Title
FR2639947B1 (fr) Derives peptidiques
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
DK22588D0 (da) Peptidderivater
EE03002B1 (et) 1,3-oksatiolaannukleosiidi analoogid, neid sisaldavad ravimpreparaadid ja nende valmistamise meetod
DK163689A (da) Peptidderivater
FI94591B (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
DK375789A (da) Peptidderivater
EE9400326A (et) Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
NZ234268A (en) Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
KR900701299A (ko) Cpf 펩티드 조성물 및 이를 사용하는 방법
FI944906A0 (fi) Uudet sykliset aminohapot ja niiden johdannaiset
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
KR880012625A (ko) 글리콜펩티드 항생물질 pa-45052 및 그의 제조방법
DK301889A (da) Peptidderivater
KR900701300A (ko) 생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
KR920700222A (ko) 동결건조된 펩티드 제제
IT1226386B (it) Procedimento di preparazione di morniflumato e analoghi.
DK177789D0 (da) Peptidderivater
IT8921567A0 (it) Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono.
DK4390A (da) Peptidderivater
GR890100827A (el) Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
NO177858C (no) Peptid
DK657189A (da) Peptidderivater
DE3869939D1 (de) Biologisch wirksame peptide.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid